BACKGROUND: The goal of periacetabular osteotomy (PAO) is to delay or prevent osteoarthritic development in dysplastic hips. However, it is unclear whether the surgical goals are achieved and if so in which patients. This information is essential to select appropriate patients for a durable PAO that achieves its goals. QUESTIONS/PURPOSES: We therefore (1) determined hip survival rates; (2) determined how many preserved hips were functionally unsuccessful after PAO; and (3) identified demographic, clinical, and radiographic factors predicting failure after PAO. METHODS: We retrospectively reviewed 316 patients (401 hips) who had PAO between December 1998 and May 2007. We evaluated radiographic parameters of dysplasia and osteoarthritis and obtained WOMAC scores. Through inquiry to the National Registry of Patients, we identified conversions to THA. Risk factors for conversion to THA were assessed. Minimum followup was 4 years (mean, 8 years; range, 4-12 years). RESULTS: The overall Kaplan-Meier hip survival rate was 74.8% at 12.4 years. A WOMAC pain score of 10 or more, suggesting clinical failure, was observed in 13% of preserved hips at last followup. Higher age, preoperative Tönnis grade of 2, incongruent hip, postoperative joint space width of 3 mm or less, and postoperative center-edge angle of less than 30° or more than 40° predicted conversion to THA. CONCLUSIONS: PAO preserved three of four hips with most functioning well at 4- to 12-year followup. When planning surgery, surgeons should attempt to achieve hip congruence and a center-edge angle of between 30° to 40° to improve the durability of PAO. LEVEL OF EVIDENCE: Level II, prognostic study. See Instructions for Authors for a complete description of levels of evidence.
BACKGROUND: The goal of periacetabular osteotomy (PAO) is to delay or prevent osteoarthritic development in dysplastic hips. However, it is unclear whether the surgical goals are achieved and if so in which patients. This information is essential to select appropriate patients for a durable PAO that achieves its goals. QUESTIONS/PURPOSES: We therefore (1) determined hip survival rates; (2) determined how many preserved hips were functionally unsuccessful after PAO; and (3) identified demographic, clinical, and radiographic factors predicting failure after PAO. METHODS: We retrospectively reviewed 316 patients (401 hips) who had PAO between December 1998 and May 2007. We evaluated radiographic parameters of dysplasia and osteoarthritis and obtained WOMAC scores. Through inquiry to the National Registry of Patients, we identified conversions to THA. Risk factors for conversion to THA were assessed. Minimum followup was 4 years (mean, 8 years; range, 4-12 years). RESULTS: The overall Kaplan-Meier hip survival rate was 74.8% at 12.4 years. A WOMAC pain score of 10 or more, suggesting clinical failure, was observed in 13% of preserved hips at last followup. Higher age, preoperative Tönnis grade of 2, incongruent hip, postoperative joint space width of 3 mm or less, and postoperative center-edge angle of less than 30° or more than 40° predicted conversion to THA. CONCLUSIONS: PAO preserved three of four hips with most functioning well at 4- to 12-year followup. When planning surgery, surgeons should attempt to achieve hip congruence and a center-edge angle of between 30° to 40° to improve the durability of PAO. LEVEL OF EVIDENCE: Level II, prognostic study. See Instructions for Authors for a complete description of levels of evidence.
Authors: Michael B Millis; Michael Kain; Rafael Sierra; Robert Trousdale; Michael J Taunton; Young-Jo Kim; Scott B Rosenfeld; Ganesh Kamath; Perry Schoenecker; John C Clohisy Journal: Clin Orthop Relat Res Date: 2009-05-07 Impact factor: 4.176
Authors: George Grammatopoulos; Jeremy Wales; Alpesh Kothari; Harinderjit S Gill; Andrew Wainwright; Tim Theologis Journal: Clin Orthop Relat Res Date: 2016-05 Impact factor: 4.176
Authors: Stephen T Duncan; Ljiljana Bogunovic; Geneva Baca; Perry L Schoenecker; John C Clohisy Journal: Clin Orthop Relat Res Date: 2015-01-31 Impact factor: 4.176
Authors: Christoph E Albers; Simon D Steppacher; Reinhold Ganz; Moritz Tannast; Klaus A Siebenrock Journal: Clin Orthop Relat Res Date: 2013-01-25 Impact factor: 4.176
Authors: Robert B Grupp; Rachel A Hegeman; Ryan J Murphy; Clayton P Alexander; Yoshito Otake; Benjamin A McArthur; Mehran Armand; Russell H Taylor Journal: IEEE Trans Biomed Eng Date: 2019-05-06 Impact factor: 4.538
Authors: James D Wylie; Jeremy A Ross; Jill A Erickson; Mike B Anderson; Christopher L Peters Journal: Clin Orthop Relat Res Date: 2017-04 Impact factor: 4.176